Home › Funds › PFM Health Sciences, LP › INDV
PFM Health Sciences, LP position in INDV
INDIVIOR PHARMACEUTICALS INC · Health Care
PFM Health Sciences, LP reported holding 401,208 shares of INDV (INDIVIOR PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$16.5M, representing 1.44% of its reported portfolio and ranking #19 among its reported holdings. PFM Health Sciences, LP has disclosed INDV holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How PFM Health Sciences, LP's INDV position evolved
PFM Health Sciences, LP first disclosed a stake in INDV in Q1 2025 at 1,159,833 shares (US$11.1M). The position peaked in Q2 2025 at 1,355,931 shares, worth US$20.0M. Across 6 filings, PFM Health Sciences, LP increased the stake 2 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 401,208 shares valued at US$16.5M — a reduction of -173,458 shares quarter over quarter.. Notable position changes include a 59% trim in Q3 2025 (shares rose 49% over the following quarter), a 36% trim in Q4 2025 (shares fell 15% over the following quarter), a 59% increase in Q1 2026 (shares rose 35% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 1.16M | $11.05M | New |
| Q2 2025 | 1.36M | $19.99M | Add |
| Q3 2025 | 561.53K | $13.54M | Reduce |
| Q4 2025 | 360.69K | $12.94M | Reduce |
| Q1 2026 | 574.67K | $17.52M | Add |
| Q2 2026 | 401.21K | $16.46M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About INDV and 13F data
INDV (INDIVIOR PHARMACEUTICALS INC) is a Health Care company. 53 other funds we track also report a position in INDV — the largest reported positions include OAKTREE CAPITAL MANAGEMENT LP (US$251.4M), Two Seas Capital LP (US$131.6M), Madison Avenue Partners, LP (US$117.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding INDV
- OAKTREE CAPITAL MANAGEMENT LP 6.13M sh · $251.40M · Q2 2026
- Two Seas Capital LP 3.67M sh · $131.61M · Q3 2026
- Madison Avenue Partners, LP 2.87M sh · $117.94M · Q2 2026
- MANGROVE PARTNERS IM, LLC 2.68M sh · $109.83M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.65M sh · $67.65M · Q2 2026
- Newtyn Management, LLC 1.31M sh · $53.58M · Q2 2026
- GENDELL JEFFREY L 1.10M sh · $44.98M · Q2 2026
- Soleus Capital Management, L.P. 1.06M sh · $43.66M · Q2 2026
- Claret Asset Management Corp 685.52K sh · $28.13M · Q2 2026
- Divisadero Street Capital Management, LP 601.86K sh · $24.69M · Q2 2026
- Melqart Asset Management (UK) Ltd 585.66K sh · $24.03M · Q2 2026
- Alta Fundamental Advisers LLC 404.53K sh · $16.60M · Q2 2026
More on PFM Health Sciences, LP
FAQ
How long has PFM Health Sciences, LP held INDV?
PFM Health Sciences, LP has disclosed INDV holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
What is PFM Health Sciences, LP's current position in INDV?
As of Q2 2026, PFM Health Sciences, LP holds 401.21K shares of INDV (INDIVIOR PHARMACEUTICALS INC), valued at $16.46M, representing 1.44% of its reported portfolio and ranking #19.
Has PFM Health Sciences, LP been buying or selling INDV?
In the latest 13F filing (Q2 2026), PFM Health Sciences, LP reduced its position in INDV. The position peaked in Q2 2025 at 1.36M shares.
Which other funds hold INDV?
Other major institutional holders of INDV include OAKTREE CAPITAL MANAGEMENT LP, Two Seas Capital LP, Madison Avenue Partners, LP, among 53 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.